sb 203580 has been researched along with knk 437 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (knk 437) | Trials (knk 437) | Recent Studies (post-2010) (knk 437) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 61 | 0 | 33 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, K; Ishizawa, M; Koike, T; Makishima, M; Takahashi, H; Uno, S; Yokota, S | 1 |
1 other study(ies) available for sb 203580 and knk 437
Article | Year |
---|---|
The heat shock protein inhibitor KNK437 induces neurite outgrowth in PC12 cells.
Topics: Acetylcholinesterase; Animals; Benzhydryl Compounds; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; HSP70 Heat-Shock Proteins; Imidazoles; Lithium Chloride; Nerve Growth Factor; Neurites; PC12 Cells; Pyridines; Pyrrolidinones; Rats; Time Factors | 2006 |